Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00964080
Recruitment Status : Unknown
Verified April 2012 by Mebiopharm Co., Ltd.
Recruitment status was:  Active, not recruiting
First Posted : August 24, 2009
Last Update Posted : December 2, 2014
Information provided by (Responsible Party):
Mebiopharm Co., Ltd

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Actual Primary Completion Date : October 2012
  Estimated Study Completion Date : April 2015